Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radioresistant tumours: From identification to targeting.
Cohen-Jonathan-Moyal É, Vendrely V, Motte L, Balosso J, Thariat J. Cohen-Jonathan-Moyal É, et al. Among authors: balosso j. Cancer Radiother. 2020 Oct;24(6-7):699-705. doi: 10.1016/j.canrad.2020.05.005. Epub 2020 Aug 1. Cancer Radiother. 2020. PMID: 32753241 Review.
Imaging issues specific to hadrontherapy (proton, carbon, helium therapy and other charged particles) for radiotherapy planning, setup, dose monitoring and tissue response assessment.
Thariat J, Hérault J, Beddok A, Feuvret L, Dauvergne D, Gérard M, Balosso J, Noël G, Valable S. Thariat J, et al. Among authors: balosso j. Cancer Radiother. 2020 Aug;24(5):429-436. doi: 10.1016/j.canrad.2020.01.010. Epub 2020 Apr 1. Cancer Radiother. 2020. PMID: 32247687 Review.
[RadioTransNet, the French network for preclinical research in oncological radiotherapy].
Bayart E, Azria D, Balosso J, Benderitter M, Cohen-Jonathan Moyal E, Delpon G, Deutsch E, Dutreix M, Lacornerie T, Romeo PH, Marchesi V, Maingon P. Bayart E, et al. Among authors: balosso j. Cancer Radiother. 2019 Oct;23(6-7):609-616. doi: 10.1016/j.canrad.2019.07.155. Epub 2019 Aug 24. Cancer Radiother. 2019. PMID: 31455590 French.
[Proton therapy in France in 2019].
Dendale R, Thariat J, Doyen J, Balosso J, Stefan D, Bolle S, Feuvret L, Poortmans P, Hannoun-Lévi JM, Bondiau PY, Micaud M, Alapetite C, Calugaru V, Habrand JL, Mahé MA. Dendale R, et al. Among authors: balosso j. Cancer Radiother. 2019 Oct;23(6-7):617-624. doi: 10.1016/j.canrad.2019.07.129. Epub 2019 Aug 30. Cancer Radiother. 2019. PMID: 31477441 French.
[Construction of radiobiological models as TCP (tumor control probability) and NTCP (normal tissue complication probability): from dose to clinical effects prediction].
Chaikh A, Thariat J, Thureau S, Tessonnier T, Kammerer E, Fontbonne C, Dubray B, Balosso J, Fontbonne JM. Chaikh A, et al. Among authors: balosso j. Cancer Radiother. 2020 Jun;24(3):247-257. doi: 10.1016/j.canrad.2019.12.004. Epub 2020 Mar 24. Cancer Radiother. 2020. PMID: 32220563 French.
RadioTransNet: Preclinical research network coordinated at the SFRO and SFPM.
Maingon P, Marchesi V, Azria D, Balosso J, Deutsch É, Cohen Jonathan-Moyal É, Giraud P, Bayart É. Maingon P, et al. Among authors: balosso j. Cancer Radiother. 2022 Feb-Apr;26(1-2):108-115. doi: 10.1016/j.canrad.2021.08.003. Epub 2021 Nov 30. Cancer Radiother. 2022. PMID: 34862132
[Why proton therapy? And how?].
Thariat J, Habrand JL, Lesueur P, Chaikh A, Kammerer E, Lecomte D, Batalla A, Balosso J, Tessonnier T. Thariat J, et al. Among authors: balosso j. Bull Cancer. 2018 Mar;105(3):315-326. doi: 10.1016/j.bulcan.2017.12.004. Bull Cancer. 2018. PMID: 29422248 Review. French.
133 results